Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
DELISTED
Vector Group Ltd.
VGR
| $27.7M | 0.01% |
2,122,479
+310,978
| +17% | +$3.87M |
2013 Q2
8 quarters
|
|
1227
Columbia Emerging Markets Consumer ETF
ECON
$296M
| $27.7M | 0.01% |
1,061,500
+88,659
| +9% | +$2.39M |
2013 Q2
8 quarters
|
|
|
CLVS
1228
DELISTED
Clovis Oncology, Inc.
CLVS
| $27.6M | 0.01% |
313,807
-7,899
| -2% | -$676K |
2013 Q2
8 quarters
|
|
1229
iShares MSCI ACWI ex US ETF
ACWX
$17.5B
| $27.5M | 0.01% |
621,873
+63,959
| +11% | +$2.97M |
2013 Q2
8 quarters
|
|
1230
Turkcell
TKC
$4.29B
| $27.4M | 0.01% |
2,388,003
+363,325
| +18% | +$4.08M |
2013 Q2
8 quarters
|
|
1231
DELISTED
Sprint Corporation
S
| $27.4M | 0.01% |
6,008,935
-113,307
| -2% | -$545K |
2013 Q3
7 quarters
|
|
1232
Labcorp
LH
$26B
| $27.4M | 0.01% |
262,664
-220,474
| -46% | -$22.9M |
2013 Q2
8 quarters
|
|
|
WNR
1233
DELISTED
Western Refining Inc
WNR
| $27.3M | 0.01% |
626,809
+240,249
| +62% | +$10.7M |
2013 Q2
8 quarters
|
|
1234
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$279M
| $27.3M | 0.01% |
377,752
+39,569
| +12% | +$2.91M |
2014 Q4
2 quarters
|
|
1235
First Trust STOXX European Select Dividend Income Fund
FDD
$896M
| $27.3M | 0.01% |
2,127,172
+159,950
| +8% | +$2.16M |
2013 Q2
8 quarters
|
|
1236
Open Text
OTEX
$6.19B
| $27.3M | 0.01% |
1,345,642
+491,628
| +58% | +$11.8M |
2013 Q2
8 quarters
|
|
1237
Stratasys
SSYS
$621M
| $27.2M | 0.01% |
778,396
-362,477
| -32% | -$15.2M |
2013 Q2
8 quarters
|
|
1238
Evercore
EVR
$9.84B
| $27.2M | 0.01% |
503,839
-141,360
| -22% | -$7.21M |
2013 Q2
8 quarters
|
|
|
GHL
1239
DELISTED
Greenhill & Co., Inc.
GHL
| $27.1M | 0.01% |
656,610
-342,565
| -34% | -$13.9M |
2013 Q2
8 quarters
|
|
1240
Ralph Lauren
RL
$23.2B
| $27.1M | 0.01% |
204,933
-13,959
| -6% | -$1.89M |
2013 Q2
8 quarters
|
|
1241
Black Stone Minerals
BSM
$3.16B
| $27.1M | 0.01% |
+1,574,443
| New | +$27.8M |
2015 Q2
0 quarters
|
|
1242
BlackRock Enhanced Global Dividend Trust
BOE
$641M
| $27.1M | 0.01% |
1,970,847
+272,862
| +16% | +$3.82M |
2013 Q2
8 quarters
|
|
1243
DELISTED
QUESTAR CORP
STR
| $27M | 0.01% |
1,292,645
+368,438
| +40% | +$8.39M |
2013 Q2
8 quarters
|
|
1244
Invesco S&P 500 Revenue ETF
RWL
$10.2B
| $27M | 0.01% |
659,504
+70,178
| +12% | +$2.93M |
2013 Q2
8 quarters
|
|
1245
Teradyne
TER
$52.9B
| $26.9M | 0.01% |
1,394,532
+1,008,976
| +262% | +$20.2M |
2013 Q2
8 quarters
|
|
1246
Marvell Technology
MRVL
$212B
| $26.9M | 0.01% |
2,039,489
-1,023,389
| -33% | -$14.7M |
2013 Q2
8 quarters
|
|
1247
DELISTED
Emerge Energy Services LP
EMES
| $26.9M | 0.01% |
744,876
+359,851
| +93% | +$15.1M |
2013 Q2
8 quarters
|
|
1248
British American Tobacco
BTI
$128B
| $26.8M | 0.01% |
495,740
-11,008
| -2% | -$607K |
2013 Q2
8 quarters
|
|
1249
Ovintiv
OVV
$18.8B
| $26.8M | 0.01% |
486,635
-254,753
| -34% | -$16.2M |
2013 Q2
8 quarters
|
|
1250
Rexford Industrial Realty
REXR
$8.26B
| $26.8M | 0.01% |
1,835,851
-13,303
| -0.7% | -$201K |
2013 Q3
7 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.